245 related articles for article (PubMed ID: 32066861)
1. Through the looking glass and what you find there: making sense of comparative genomic hybridization and fluorescence in situ hybridization for melanoma diagnosis.
Miedema J; Andea AA
Mod Pathol; 2020 Jul; 33(7):1318-1330. PubMed ID: 32066861
[TBL] [Abstract][Full Text] [Related]
2. The p16-Ki-67-HMB45 Immunohistochemistry Scoring System is Highly Concordant With the Fluorescent In Situ Hybridization Test to Differentiate Between Melanocytic Nevi and Melanomas.
Uguen A; Uguen M; Guibourg B; Talagas M; Marcorelles P; De Braekeleer M
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):361-367. PubMed ID: 27490764
[TBL] [Abstract][Full Text] [Related]
3. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
Senetta R; Paglierani M; Massi D
Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
[TBL] [Abstract][Full Text] [Related]
5. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry.
Nagarajan P; Tetzlaff MT; Curry JL; Prieto VG
Actas Dermosifiliogr; 2017; 108(1):17-30. PubMed ID: 27344067
[TBL] [Abstract][Full Text] [Related]
6. Main clues in the pathologic diagnosis of melanoma: is molecular genetics helping?
Ferrara G; Senetta R; Paglierani M; Massi D
Dermatol Ther; 2012; 25(5):423-31. PubMed ID: 23046021
[TBL] [Abstract][Full Text] [Related]
7. Molecular testing for melanocytic tumors: a practical update.
Andea AA
Histopathology; 2022 Jan; 80(1):150-165. PubMed ID: 34958511
[TBL] [Abstract][Full Text] [Related]
8. A proposal for improving multicolor FISH sensitivity in the diagnosis of malignant melanoma using new combined criteria.
Kerl K; Palmedo G; Wiesner T; Mentzel T; Rütten A; Schärer L; Paredes B; Hantschke M; Kutzner H
Am J Dermatopathol; 2012 Aug; 34(6):580-5. PubMed ID: 22668575
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of Preferentially Expressed Antigen in Melanoma Immunohistochemistry and Diagnostic Gene Expression-Profiling Assay in Challenging Melanocytic Proliferations.
Casillas AC; Muhlbauer A; Barragan VA; Jefferson I; Speiser JJ
Am J Dermatopathol; 2024 Mar; 46(3):137-146. PubMed ID: 38354382
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal copy number analysis in melanoma diagnostics.
North JP; Vemula SS; Bastian BC
Methods Mol Biol; 2014; 1102():199-226. PubMed ID: 24258981
[TBL] [Abstract][Full Text] [Related]
12. microRNA in situ hybridization for miR-211 detection as an ancillary test in melanoma diagnosis.
Babapoor S; Horwich M; Wu R; Levinson S; Gandhi M; Makkar H; Kristjansson A; Chang M; Dadras SS
Mod Pathol; 2016 May; 29(5):461-75. PubMed ID: 26916074
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma.
Gerami P; Jewell SS; Morrison LE; Blondin B; Schulz J; Ruffalo T; Matushek P; Legator M; Jacobson K; Dalton SR; Charzan S; Kolaitis NA; Guitart J; Lertsbarapa T; Boone S; LeBoit PE; Bastian BC
Am J Surg Pathol; 2009 Aug; 33(8):1146-56. PubMed ID: 19561450
[TBL] [Abstract][Full Text] [Related]
14. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
[TBL] [Abstract][Full Text] [Related]
15. Clinical application and limitations of the fluorescence in situ hybridization (FISH) assay in the diagnosis and management of melanocytic lesions: a report of 3 cases.
Nijhawan RI; Votava HJ; Mariwalla K
Cutis; 2012 Oct; 90(4):189-95. PubMed ID: 23259206
[TBL] [Abstract][Full Text] [Related]
16. An Update Regarding the Molecular Genetics of Melanocytic Neoplasms and the Current Applications of Molecular Genetic Technologies in Their Diagnosis and Treatment.
Kiavash K; Bluth MH; Thompson AD
Clin Lab Med; 2018 Jun; 38(2):385-399. PubMed ID: 29776637
[TBL] [Abstract][Full Text] [Related]
17. Detection of copy number variations in melanocytic lesions utilising array based comparative genomic hybridisation.
Mesbah Ardakani N; Thomas C; Robinson C; Mina K; Harvey NT; Amanuel B; Wood BA
Pathology; 2017 Apr; 49(3):285-291. PubMed ID: 28274670
[TBL] [Abstract][Full Text] [Related]
18. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
[TBL] [Abstract][Full Text] [Related]
19. The utility of PRAME immunohistochemistry in the evaluation of challenging melanocytic tumors.
Alomari AK; Tharp AW; Umphress B; Kowal RP
J Cutan Pathol; 2021 Sep; 48(9):1115-1123. PubMed ID: 33660310
[TBL] [Abstract][Full Text] [Related]
20. Molecular Melanoma Diagnosis Update: Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing.
Lang UE; Yeh I; McCalmont TH
Clin Lab Med; 2017 Sep; 37(3):473-484. PubMed ID: 28802496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]